New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

First commercially available cell culture solution for HEK293 cells and perfusion -– optimized for high cell density (HCD), intensified processes and perfusion cultures Additional capabilities for ...

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx ...

Melanoma incidence in the United States has increased during recent decades to an estimated number of 76,100 new cases in 2014, 1 comprising 4.6% of all new cancer cases. In approximately 5% to 8% of ...

A UGT1A1 genotype-directed phase I study of irinotecan (CPT-11) combined with fixed dose of capecitabine in patients with metastatic colorectal cancer (mCRC) No significant financial relationships to ...

Isolated limb perfusion (ILP) is a limb salvage surgical modality used to deliver chemotherapy and biologic agents to locally advanced and recurrent extremity soft tissue sarcoma (STS), and may be ...

Gene therapy approaches delivering fibroblast growth factor-2 (FGF-2) have shown promise as a potential treatment for increasing blood flow to ischemic limbs. Currently, effective noninvasive ...

There are estimated to be 13 distinct hereditary renal cell carcinoma (RCC) syndromes, each of which Arterial spin labeled (ASL) perfusion magnetic resonance imaging (MRI) is a non–contrast-based, ...

KAPOSI'S sarcoma, or "idiopathic multiple hemorrhagic sarcoma," was first described as a clinical entity by Kaposi in 1872. The disease is progressive, and it exhibits a wide range of clinical and ...

FUJIFILM Biosciences, a global leader in the innovation and manufacture of cell culture solutions for the Life Science market, today announced the commercial launch of BalanCD HEK293 Perfusion A.